Injective price prediction: Downtrend persists even after upgrade news? INJ falls 7.14%
Injective (INJ) is trading at $3.19, sitting slightly below both the MA-20 at $3.23 and well under the MA-50 at $4.13 and MA-200 at $8.08, indicating bearish pressure across short, medium, and long-term trends. The Ichimoku Kijun is at $3.58, representing immediate resistance above the current price.
Highlights
- Injective introduced a dynamic INJ gas fee mechanism via a chain upgrade to optimize revenue and reduce on-chain user costs.
- This upgrade aims to improve transaction efficiency by making gas fees more responsive to network demand, supporting Injective's ongoing protocol evolution.
- INJ trades at $3.19 below MA-20/MA-50/MA-200, with immediate resistance at $3.58 and a base case range of $2.90–$3.40 amid persistent bearish momentum.
Dynamic gas fee upgrade drives protocol evolution and user efficiency
Injective has introduced a new chain upgrade featuring a dynamic INJ gas fee mechanism aimed at optimizing revenue generation and reducing costs for all on-chain users. This enhancement is designed to improve transaction efficiency and make gas fees more responsive to network demand, enhancing the user experience across the ecosystem. The update highlights Injective’s continued effort to drive adoption and support its protocol’s evolution.
Bearish momentum dominates as intraday signals confirm weak sentiment
Momentum is weak, with the MACD flashing a strong sell and the ADX on the daily chart indicating buyers retain some strength but not enough to offset prevailing downside momentum; weekly MACD and RSI are also firmly bearish. The RSI sits at 45.47 on the daily and 30.86 on the weekly, suggesting the asset is approaching but not yet in oversold territory, while the Stochastic RSI and CCI give neutral to oversold signals, highlighting mixed short-term sentiment. Bull/Bear Power signals mild buyer advantage, but the daily change of 7.14% down with no gap at the open and the current price near today’s low underscores persistent selling pressure, high intraday volatility, and a clear trend of weakness since the session started. Intraday momentum signals and price action broadly confirm each other, though there is some divergence between oversold/neutral oscillators and bearish momentum.
Sideways to lower price bias as upside reversal remains unlikely
For the next five trading days, the expected price range is adjusted to $2.90 – $3.40 to reflect typical volatility relative to current levels. There is a very low probability (less than 20%) of a significant price increase, making a further decline the more likely outcome. In the baseline scenario, INJ moves sideways between $2.90 and $3.40. A bullish reversal would require a sustained break above the $3.58 Ichimoku Kijun resistance, while a drop below $2.90 may accelerate further losses.
Previously it was reported that INJ attempted recovery from a sustained downtrend, with price consolidating below all major moving averages and immediate resistance identified near $3.5 to $3.65. Momentum remains neutral, with RSI at 47.37, as price tests key levels and a move above the 20-day EMA would signal stabilization, while a break below immediate support could see further downside risk.
Latest Injective News
- Forex
- Crypto